[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE252913T1 - Vorbeugung einer krankheit mit diabetes charakter - Google Patents

Vorbeugung einer krankheit mit diabetes charakter

Info

Publication number
ATE252913T1
ATE252913T1 AT96921919T AT96921919T ATE252913T1 AT E252913 T1 ATE252913 T1 AT E252913T1 AT 96921919 T AT96921919 T AT 96921919T AT 96921919 T AT96921919 T AT 96921919T AT E252913 T1 ATE252913 T1 AT E252913T1
Authority
AT
Austria
Prior art keywords
diabetes
prevention
type disease
type
disease
Prior art date
Application number
AT96921919T
Other languages
English (en)
Inventor
Thomas Dyrberg
Anne Worsaae
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE252913T1 publication Critical patent/ATE252913T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT96921919T 1995-06-30 1996-07-01 Vorbeugung einer krankheit mit diabetes charakter ATE252913T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK76595 1995-06-30
PCT/DK1996/000297 WO1997002043A1 (en) 1995-06-30 1996-07-01 Prevention of a disease having the characteristics of diabetes

Publications (1)

Publication Number Publication Date
ATE252913T1 true ATE252913T1 (de) 2003-11-15

Family

ID=8097303

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921919T ATE252913T1 (de) 1995-06-30 1996-07-01 Vorbeugung einer krankheit mit diabetes charakter

Country Status (7)

Country Link
US (3) US6274549B1 (de)
EP (1) EP0835129B1 (de)
JP (1) JPH11509195A (de)
AT (1) ATE252913T1 (de)
AU (1) AU6299596A (de)
DE (1) DE69630527T2 (de)
WO (1) WO1997002043A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU781405B2 (en) * 1998-02-23 2005-05-19 Neurocrine Biosciences, Inc. Methods for treatment of diabetes using peptide analogues of insulin
BR9908178A (pt) * 1998-02-23 2002-01-15 Neurocrine Biosciences Inc Processos para tratamento de diabetes usando análogos peptìdios de insulina
US6562942B1 (en) 1999-02-23 2003-05-13 Neurocrine Biosciences, Inc. Methods for treatment of diabetes using peptide analogues of insulin
JPH11353404A (ja) * 1998-06-11 1999-12-24 Hitachi Ltd 電子カルテシステム
CN1909930B (zh) 2004-01-21 2015-12-16 诺和诺德医疗保健公司 转谷氨酰胺酶介导的肽的接合
NO345613B1 (no) 2004-07-19 2021-05-10 Biocon Ltd Insulinoligomerkonjugater, formuleringer og bruk derav
CA2702892C (en) 2007-10-16 2017-02-28 Biocon Limited An orally administerable solid pharmaceutical composition and a process thereof
PL2254906T3 (pl) 2008-03-18 2017-04-28 Novo Nordisk A/S Stabilizowane względem proteaz, acylowane analogi insuliny
ES2955693T3 (es) 2012-12-24 2023-12-05 Neurogastrx Inc Métodos para el tratamiento de trastornos del tracto GI
US9844554B2 (en) 2014-06-24 2017-12-19 Neurogastrx, Inc. Prodrugs of metopimazine
KR102374354B1 (ko) 2016-12-16 2022-03-15 노보 노르디스크 에이/에스 인슐린 함유 약제학적 조성물
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
US5422339A (en) 1991-03-19 1995-06-06 Joslin Diabetes Center, Inc. Peptides having insulin autoantibody but not insulin receptor binding capacity
US5891435A (en) * 1993-04-16 1999-04-06 Research Corporation Technologies, Inc. Methods and compositions for delaying or preventing the onset of autoimmune disease
AU1864195A (en) * 1994-03-07 1995-09-25 Auckland Uniservices Limited Prevention of diabetes
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
WO1997009061A1 (en) 1995-09-06 1997-03-13 Alexion Pharmaceuticals, Inc. Treatment of diabetes via administration of hormonally ineffective insulin

Also Published As

Publication number Publication date
US6274549B1 (en) 2001-08-14
EP0835129A1 (de) 1998-04-15
EP0835129B1 (de) 2003-10-29
DE69630527T2 (de) 2004-08-05
WO1997002043A1 (en) 1997-01-23
JPH11509195A (ja) 1999-08-17
US20010021696A1 (en) 2001-09-13
DE69630527D1 (de) 2003-12-04
AU6299596A (en) 1997-02-05
US20010041669A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
ATE252913T1 (de) Vorbeugung einer krankheit mit diabetes charakter
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
ATE258797T1 (de) Verwendung von amifostin
KR920700625A (ko) 고혈압 치료를 위한 신장에 선택적인 프로드러그(Prodrug)
WO1992019234A3 (en) Method of treating/preventing substance abuse using 1-alkyl-5(substituted oxy)-2-aminotetralins
BR9810444A (pt) Tratamento de diabete com rosiglitazona e insulina
DE68907635D1 (de) Loetmaterial fuer brillengestelle und brillengestelle, bei denen dieses loetmaterial verwendet ist.
DE69116224D1 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
DE69106777D1 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
ATE289819T1 (de) Gedächnissverbesserung durch verabreichung von delta-5-androsten-3-beta-ol-7,17-dion und 3-beta- estern desselben
BR9810142A (pt) Tratamento de diabete com tiazolidinadiona e sulfonil-uréia
ATE69542T1 (de) Kuenstlicher augenbrauenkoerper.
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
PT869785E (pt) 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
BR9713349A (pt) Método e dispositivo para adaptar uma estrutura de ponte para ajustar elementos de ancoragem em uma mandìbula de paciente.
IT9048106A0 (it) Associazione medicamentosa per il trattamento dell'ipertensione e dell'insufficienza cardiaca congestiva. (caso 100-7516)
BR9703451C1 (pt) Composto natural para o tratamento de diabete ecâncer etc
FR2700621B1 (fr) Lunettes comportant un écran équipé d'un ensemble correcteur.
ATE198476T1 (de) Alternative kristallform von tazofelon ((+,-)-5- ((3,5-bis(1,1-dimethylethyl)-4- hydroxyphenyl)methyl)-4-thiazolidinon)
DE69101077D1 (de) System und Verfahren zum Zusammenbau einer Orthese.
IT8603418A1 (it) Calzatura anatomica per la prevenzione e la correzione dell'alluce valgo.
IT8603418A0 (it) Calzatura anatomica per la prevenzione e la correzione dell'alluce valgo
IT8783648A0 (it) Modulazione dell'esposizione di uno strato di fotoresist in corrispondenza di bordi di aperture con metodi diffrattivi.
FI951741A (fi) Hiirialusta

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties